In the BioHarmony Drug Report Database

"Preview" Icon

Isotretinoin

Absorica, Absorica Ld, Accutane (isotretinoin) is a small molecule pharmaceutical. Isotretinoin was first approved as Absorica on 1982-05-07. It is used to treat acne vulgaris, leukemia, and neuroblastoma in the USA. Amnesteem’s patents are valid until 2035-08-04 (FDA).

 

Trade Name

 

Absorica, Absorica Ld, Accutane
 

Common Name

 

isotretinoin
 

ChEMBL ID

 

CHEMBL547
 

Indication

 

acne vulgaris, leukemia, neuroblastoma
 

Drug Class

 

Retinol derivatives

Image (chem structure or protein)

Isotretinoin structure rendering